Published on 17 May 2023 on Investing.com
Horizon Therapeutics Options Trader Betting On A Major Dip For Stock By January 2024 By Benzinga
Horizon Therapeutics Options Trader Betting On A Major Dip For Stock By January 2024
FTC Allows Amgen (AMGN) to Proceed With $28B Horizon Buyout
On Friday, the Federal Trade Commission (“FTC”) allowed biotech giant Amgen AMGN to complete its ...
Horizon (HZNP) Up as FTC Pauses Acquisition by Amgen Lawsuit
The Federal Trade Commission ("FTC"), through a filing in the Federal Court, temporarily suspende...
...Not Responsible For Deadly Lahaina Fire, China Targets Stock Market Revival, FTC Pauses Legal...
Reuters Walmart Settles Lawsuit Regarding Allegations Of Light-Bulb Patent Infringement
AlloVir Stock: An Intriguing $3 Biotech Concern (NASDAQ:ALVR)
AlloVir was founded in 2013 as AdCyte (later ViraCyte) and went public in August 2020, raising ne...
Horizon (HZNP) Q2 Earnings Top, Krystexxa & Uplizna Boost Sales
Horizon Therapeutics plc HZNP delivered second-quarter 2023 adjusted earnings of $1.20 per share,...
Horizon's (HZNP) Tepezza Study in Japan for TED Meets Goal
Horizon Therapeutics HZNP announced positive top-line results from its ongoing phase III study on...
Anticompetitive Behavior At United Therapeutics, Regeneron, And The FTC
Antitrust law was intended to protect customers from abuses of pricing power. Instead of protecti...
10 Best Stocks to Buy According to Billionaire Paul Tudor Jones
In this piece, we will take a look at the ten best stocks to buy according to billionaire Paul Tu...
Horizon Therapeutics Options Trader Betting On A Major Dip For Stock By January 2024 By Benzinga
Horizon Therapeutics Options Trader Betting On A Major Dip For Stock By January 2024
FTC Challenges Amgen's (AMGN) $28B Acquisition of Horizon
On Tuesday, the Federal Trade Commission (“FTC”) filed a lawsuit in Federal Court to halt biotech...